The company's main products are self-developed national first-class new drugs-Sutaisheng, a mouse nerve growth factor for injection, and Shutaiqing, the only cathartic drug in China. In addition, it also produces aspirin enteric-coated tablets, gliclazide tablets and nabumetone capsules. At the same time, there are still many countries where the first-class new drugs and new drugs with independent intellectual property rights are in different stages of research and development or declaration from laboratory to clinical trials. In the next three to five years, the company will put a number of new products with independent intellectual property rights on the market one after another.
The company was recognized as a high-tech enterprise in Beijing and Zhongguancun in June 5438+February 2008. From June 5438 to February 2009, it was jointly named as an innovative enterprise in Zhongguancun National Independent Innovation Demonstration Zone by Beijing Municipal Government, Ministry of Science and Technology and Chinese Academy of Sciences, undertaking a number of national and municipal scientific and technological innovation and industrialization projects. The main products have been successively recognized as "National Torch Program Products", "Beijing High-tech Achievements Transformation Project", "National Biomedical High-tech Industrialization Demonstration Project" and "Beijing Independent Innovation Products", and won the third prize of Beijing Science and Technology Progress Award.